NutriBand (NTRB) Non Operating Income (2023 - 2026)
NutriBand (NTRB) posted Non Operating Income of $12395.0 for Q2 2026, down 76.55% sequentially from $52856.0 in Q1 2026, and down 49.67% YoY from $24628.0 in Q2 2025.
NutriBand (NTRB) Non Operating Income (2023 - 2026) Analysis & Trends
NutriBand has reported Non Operating Income for 4 years, with the latest figure at $12395.0 in Q2 2026.
- Quarterly Non Operating Income fell 49.67% year-over-year to $12395.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $76096.0 (up 146.25% YoY) and the FY2026 annual result came in at $88329.0, up 144.66% from the prior year.
- Non Operating Income slipped to $12395.0 in Q2 2026 per NTRB's latest filing, from $52856.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $64204.0 in Q4 2024 and troughed at -$574617.0 in Q1 2024.
- A 4-year average of -$59423.9 and a median of $5422.5 in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income sank 5832.26% in 2024, then surged 386.37% in 2025.
- Over 4 years, Non Operating Income stood at -$36435.0 in 2023, then soared by 276.22% to $64204.0 in 2024, then tumbled by 87.59% to $7969.0 in 2025, then surged by 55.54% to $12395.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $12395.0, $52856.0, and $7969.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 12,395.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 12,395.00 |
| Jan 31, 2026 | 52,856.00 |
| Oct 31, 2025 | 7,969.00 |
| Jul 31, 2025 | 2,876.00 |
| Apr 30, 2025 | 24,628.00 |
| Jan 31, 2025 | 42,345.00 |
| Oct 31, 2024 | 64,204.00 |
| Jul 31, 2024 | -295,723.00 |
| Apr 30, 2024 | -8,600.00 |
| Jan 31, 2024 | -574,617.00 |
| Oct 31, 2023 | -36,435.00 |
| Jul 31, 2023 | -4,985.00 |